In den Warenkorb
Bestellen Sie auch über:
+33 (0)1 76 63 32 65
+33 (0)1 74 18 08 22

Ubiqutin Antikörper

Antigen

Ubiqutin

Klonalität Monoklonal (FPM1)
Wirt

Maus

Reaktivität

Human

Applikation
Immunhistochemie (IHC)
2 Publikationen vorhanden
Produktnummer ABIN108023
Menge 1ml  (100ug/ml approximately)
Preis 314,42 €   Zzgl. Versandkosten €40,00 und MWSt
Lieferung nach
Verfügbarkeit Lieferung in 5 Werktagen

Produktbeschreibung

Immunogen BALB/C mice were immunized with purified human ubiquitin.
Format Supernatant
Isotyp IgG1  (Passende Sekundärantikörper)
Klon FPM1
Spezifität This antibody recognizes neurofibrillary tangles in Alzheimer

Anwendungen

Applikationshinweise Titer/Working Dilution: This antibody may be diluted to a titer of 1:10-1:25 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Suitable for formalin/paraffin tissues. Positive Control: Alzheimer brain. Cellular localization: Nuclear, cytoplasmic and cell membrane
Konzentration 100ug/ml approximately
Buffer This antibody is supplied as tissue culture supernatant containing azide as the preservative.
Lagerung Store the antibody 2-8o c. Do not use it beyond the expiration date stated on the label.
Forschungsgebiet Proteasen, Aminosäuren
Beschränkungen Für Forschungszwecke. Als CE-zertifizierter Antikörper in der Europäischen Union für In Vitro Diagnostik (IVD) zugelassen.

Publikationen

Publikationen Lennox, Lowe, Morrell et al.: "Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease." in: Journal of neurology, neurosurgery, and psychiatry, Vol. 52, Issue 1, pp. 67-71, 1989 (PubMed).

Lowe, Lennox, Jefferson et al.: "A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin." in: Neuroscience letters, Vol. 94, Issue 1-2, pp. 203-10, 1989 (PubMed).